Arrowhead Pharmaceuticals (ARWR) Cash from Investing Activities (2011 - 2026)
Arrowhead Pharmaceuticals' Cash from Investing Activities was $43.68 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 69.1% from $141.39 million a year earlier.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Cash from Investing Activities (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Arrowhead Pharmaceuticals' Cash from Investing Activities was -$801.72 million through Jun 30, 2026; for FY2025 (ended Sep 30, 2025), it was -$129.29 million.
- In earlier fiscal years, Cash from Investing Activities was -$420.07 million in FY2024, -$96.16 million in FY2023, -$5.42 million in FY2022 and -$141.68 million in FY2021.
- Quarterly Cash from Investing Activities has moved between -$894.28 million (fiscal Q2 2026) and $141.39 million (fiscal Q3 2025) over five years.
- Per Business Quant data, ARWR's Cash from Investing Activities in the three fiscal quarters before Q3 2026 was -$894.28 million (Q2 2026), -$23.74 million (Q1 2026) and $72.62 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Arrowhead Pharmaceuticals | 9.06 Bn | 3.84 Bn | - | 43.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.68 Mn |
| Mar 31, 2026 | -894.28 Mn |
| Dec 31, 2025 | -23.74 Mn |
| Sep 30, 2025 | 72.62 Mn |
| Jun 30, 2025 | 141.39 Mn |
| Mar 31, 2025 | -420.21 Mn |
| Dec 31, 2024 | 76.91 Mn |
| Sep 30, 2024 | -222.92 Mn |
| Jun 30, 2024 | 6.95 Mn |
| Mar 31, 2024 | -268.94 Mn |
| Dec 31, 2023 | 64.84 Mn |
| Sep 30, 2023 | 30.51 Mn |
| Jun 30, 2023 | -9.91 Mn |
| Mar 31, 2023 | -36.07 Mn |
| Dec 31, 2022 | -80.69 Mn |
| Sep 30, 2022 | 36.45 Mn |
| Jun 30, 2022 | 61.28 Mn |
| Mar 31, 2022 | -69.76 Mn |
| Dec 31, 2021 | -33.39 Mn |
| Sep 30, 2021 | -118.25 Mn |
API Access
Arrowhead Pharmaceuticals Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();